TSPO and Parkinson disease: A study using a TSPO ligand demonstrated increased cortical microglial activation in patients with Parkinson’s disease (with and without dementia) and identified increased left parietal neuroinflammation in patients with Parkinson’s dementia compared to Parkinson’s patients without dementia (Edison et al., 2013).